Clinical trial / 2016
Flaxseed and Vitex agnus both significantly reduced cyclical breast pain compared to placebo over two months in women.
A randomized controlled trial evaluated 159 women allocated to receive 25g daily flaxseed powder plus placebo, daily 3.2-4.8mg Vitex agnus tablet plus placebo, or double placebo for two months. Mean NDBP score was significantly lower than control at month one for flaxseed (adjusted mean difference: -3.1, 95% CI: -4.2 to -2.0) and V. agnus (-3.3, 95% CI: -4.3 to -2.2). At month two, reductions remained significantly greater than control for flaxseed (-7.0, 95% CI: -8.1 to -5.9) and V. agnus (-6.4, 95% CI: -7.5 to -5.3). Authors noted further studies are needed to evaluate long-term effectiveness and sustainability after treatment cessation.
- Study type
- Randomized controlled trial
- Who was studied
- 159 women referred to health centers of Tabriz, Iran
- What was measured
- Nominal day breast pain (NDBP) at baseline, first, and second month
THE PAPER
Effects of Vitex agnus and Flaxseed on cyclic mastalgia: A randomized controlled trial.
Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Ahmadpour P, Javadzadeh Y. Complement Ther Med, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.